Complementation in cells cotransfected with a mixture of wild-type and mutant human immunodeficiency virus (HIV) influences the replication capacities and phenotypes of mutant variants in a single-cycle HIV resistance assay

Journal of Clinical Microbiology
Hongmei MoAkhteruzzaman Molla

Abstract

The impact of cotransfection of mixtures of mutant and wild type (WT) virus on the observed phenotype and replication capacity (RC) in a single-cycle human immunodeficiency virus (HIV) phenotypic assay has been investigated by cotransfecting mutant HIV clones expressing the firefly luciferase expression gene with a WT clone expressing Renilla luciferase. Four mutant constructs with different genotypes displayed <1% RC when transfected alone. Cotransfection of as little as 9% of the WT clone resulted in an 18- to 33-fold increase in the RC of the mutant clones. In addition, the 50% inhibitory concentration (IC(50)) of lopinavir against seven mutant clones decreased by up to 97% after incremental cotransfection of 9 to 50% of the WT clone. The enhancement of RC and decrease in IC(50) for mutant variants following cotransfection with the WT variant appear to be due to complementation rather than genetic recombination. These findings suggest that the RC and susceptibility of plasma isolates from patients who are off therapy or not adherent to treatment, in which WT virus may expand to significant levels, should be interpreted with caution.

References

Jul 9, 1999·Reviews in Medical Virology·M J Potash, D J Volsky
Aug 19, 1999·Protein Science : a Publication of the Protein Society·D XieJ W Erickson
Mar 18, 2000·Antimicrobial Agents and Chemotherapy·C J PetropoulosJ M Whitcomb
Apr 25, 2000·Antiviral Research·D K JardineC J Birch
Mar 7, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G J Hanna, R T D'Aquila
Apr 5, 2002·Clinical Microbiology Reviews·Robert W Shafer
Oct 9, 2002·Journal of Virological Methods·Mutsunori IgaHirohito Tsubouchi
Jul 19, 2003·The Journal of Infectious Diseases·Matthew J GonzalesRobert W Shafer

❮ Previous
Next ❯

Citations

Jan 24, 2008·Antimicrobial Agents and Chemotherapy·Tatyana DekhtyarAkhteruzzaman Molla
Nov 16, 2005·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Eva PovedaVincent Soriano
Jan 11, 2007·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Kristina AllersKarin J Metzner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.